UBC Biotech Spin-Off Raises $75M to Bring Cancer Treatments to Patients

Alpha-9 Theranostics, a UBC spin-off company founded by three university researchers, has raised $75 million to develop next-generation radiopharmaceuticals that promise to meaningfully improve treatment for people with cancer.